Cardlytics Announces Board and Executive Changes
Ticker: CDLX · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-changes, governance
Related Tickers: CDLX
TL;DR
Cardlytics shakes up its board and exec team, new directors appointed.
AI Summary
Cardlytics, Inc. announced on June 23, 2025, a series of executive and board changes. These include the departure of Director Jonathan L. Sokoloff and the appointment of new directors, including David L. K. Lee and David M. Z. Lee. The company also announced changes to its compensation committee, with new members appointed.
Why It Matters
Changes in board composition and executive roles can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board and executive changes can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- Cardlytics, Inc. (company) — Registrant
- Jonathan L. Sokoloff (person) — Departing Director
- David L. K. Lee (person) — Appointed Director
- David M. Z. Lee (person) — Appointed Director
FAQ
Who has departed from the Cardlytics board?
Jonathan L. Sokoloff has departed from the Cardlytics board.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 23, 2025.
What is Cardlytics, Inc.'s state of incorporation?
Cardlytics, Inc. is incorporated in Delaware.
Who are the newly appointed directors at Cardlytics?
David L. K. Lee and David M. Z. Lee have been appointed as new directors.
What is the business address of Cardlytics, Inc.?
The business address is 675 Ponce de Leon Avenue NE, Suite 4100, Atlanta, Georgia 30308.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 by Jonathan L. Sokoloff regarding Cardlytics, Inc. (CDLX).